Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Multicentre Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Repeated Doses of INDV-6001 in Adults With Moderate to Severe Opioid Use Disorder

NCT06576843 is registered in ClinicalTrials.gov with Indivior Inc. as lead sponsor.

NCT NCT06576843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06576843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Multicentre Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Repeated Doses of INDV-6001 in Adults With Moderate to Severe Opioid Use Disorder
Lead sponsor
Indivior Inc.
Phase
Phase 2
Overall status
Completed
Start date
September 17, 2024
Completion date
January 21, 2026
Enrollment
123 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

moderate to severe opioid use disorder